Skip to main content
Caplight Logo









Molecular Forecaster Inc.

Molecular Forecaster Inc.

Private
MontrealHealthcare & Life Scienceshttps://molecularforecaster.com/

Last Round

Grant

Sep 28, 2021

Total Funding Raised

$787,000

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Molecular Forecaster Inc. is a computational chemistry company that provides research-as-a-service (RaaS) and proprietary software for small molecule drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

computational chemistrydrug discoveryvirtual screeningin silico drug discoverybinding affinity predictionmolecular dockingmedicinal chemistrylead optimizationresearch-as-a-serviceRaaScontract research organizationCROsmall-molecule discoverystructure-activity relationshipSARai drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Molecular Forecaster Inc. Comparables

Compare Molecular Forecaster Inc. with similar companies based on industry and business-model similarity.

Molecular Forecaster Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioSolveIT
87%
Molsoft LLC
86%
Chemical Computing Group
84%

Molecular Forecaster Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 28, 2021

Key People

Founding team and executive leadership

Josh Pottel

CEO

Executive Team

Molecular Forecaster Inc. Investors

Notable investors and investment history

Molecular Forecaster Inc. investors
InvestorRounds
Investissement QuébecGrant
Génome QuébecGrant
Consortium Québécois sur la découverte du médicamentGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Grew 22% QoQ, from 18 to 22 employees.

  • Jul 26, 2026

    Monthly visitors increased 143% MoM, reaching 1.4K.

Molecular Forecaster Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Molecular Forecaster Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Molecular Forecaster Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersMontreal
Employee Range22
Year Founded2010
Last FundingSep 28, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?